BupPractice.com Information About Getting Your Waiver

If you do not have an account: This page is part of a larger Buprenorphine training activity provided by Clinical Tools, Inc. Our DATA 2000/CARA-qualifying Buprenorphine training provides the current information for physicians, nurse practitioners, and physician assistants on prescribing buprenorphine as an office-based treatment for opioid use disorder. Please refer to the Buppractice.com homepage to sign-up and begin the activity!

Current accounts: If you see this message, the system has logged you out because of inactivity. To resume:

  1. Log In
  2. Go To Activity Homepage (Module list page)
  3. Re-Enter Module To Resume Training

If you've successfully requested the required credit for your buprenorphine training activity and obtained your training certificate(s) (one 8 hour certificate for physicians, and two certificates for NPs and PAs - one 8 hour BupPractice certificate and one 16 hour SBIRT+OpioidRisk certificate), the next step is to request your waiver! Providers who have completed buprenorphine training must submit a Notification of Intent form (AKA "Buprenorphine Waiver Notification") to CSAT/SAMHSA, using an online form available on SAMHSA's website along with electronic copies of training certificates, before they start prescribing. See below for details.

How To Submit Your Waiver Notification of Intent (NOI) Form) - It's Easy!
Submit Your Waiver Online!
  1. Submit the online Buprenorphine Waiver Notification form. You must submit this form if you plan on prescribing buprenorphine.
  2. You must ALSO send your training certificates electronically, via email to infobuprenorphine@samhsa.hhs.gov OR via fax to 301-576-5237.
  3. Allow 45 days for CSAT to review your waiver notification form. Note that we send notification of your completion of the training to them within around a week after your completion to confirm your completion.
  4. Once the application process is complete and the application is approved, SAMHSA will email a letter that confirms the waiver and includes the provider’s prescribing identification number. If it has been more than 45 days since a provider has submitted an application or if a provider submitted an application and did not receive an acknowledgement of receipt, contact CSAT's Buprenorphine Information Center at 866-BUP-CSAT (866-287-2728) or send CSAT an email:  infobuprenorphine@samhsa.hhs.gov

Physicians: After your waiver notification has been reviewed, you will receive a prescribing identification number ("X" number) from the DEA via email. You will need to write this number on all buprenorphine prescriptions that you write. Your regular DEA number will not change.

NPs and PAs: You will be issued a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number. 

Providers who have completed buprenorphine training and are interested in applying to treat one patient emergently immediately should refer to procedures on SAMHSA's website page on obtaining a waiver.

  • SAMHSA will have proof of your training that we send to them, if you completed it in recent years; if it has been a while, contact your training organization (feedback@clinicaltools.com ) for help with obtaining proof of your completion
  • In addition to the information we send SAMHSA, they now require an electronic version of your training certificates via email to infobuprenorphine@samhsa.hhs.gov OR via fax to 301-576-5237.
  • If you consent to release your information to SAMHSA, patients and health care providers will be able to find you on the SAMHSA Buprenorphine Physician and Treatment Program Locator Website.

For more on getting your waiver and advice on where to start in getting your practice ready: Visit our guide Next Steps. Get Started Prescribing Buprenorphine

  • For resources to use with your patients:

    Review our latest BupPatient Resources. This page provides a consolidated list of office-based opioid treatment (OBOT) resources for patients.

Help! - I Have More Questions.

Do you have more questions? Please browse the Buprenorphine Waiver Management Section on the SAMHSA/CSAT website or refer to our Site FAQs.

If you don't see your question there, please Contact Us.